JPS6210517B2 - - Google Patents

Info

Publication number
JPS6210517B2
JPS6210517B2 JP56029427A JP2942781A JPS6210517B2 JP S6210517 B2 JPS6210517 B2 JP S6210517B2 JP 56029427 A JP56029427 A JP 56029427A JP 2942781 A JP2942781 A JP 2942781A JP S6210517 B2 JPS6210517 B2 JP S6210517B2
Authority
JP
Japan
Prior art keywords
substance
water
methanol
culture
silica gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56029427A
Other languages
Japanese (ja)
Other versions
JPS57144294A (en
Inventor
Teruaki Shiroza
Toyonari Endo
Haruo Seto
Nozomi Ootake
Hiroshi Yonehara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIPPON KOSEI BUTSUSHITSU GAKUJUTSU KYOGIKAI
Original Assignee
NIPPON KOSEI BUTSUSHITSU GAKUJUTSU KYOGIKAI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NIPPON KOSEI BUTSUSHITSU GAKUJUTSU KYOGIKAI filed Critical NIPPON KOSEI BUTSUSHITSU GAKUJUTSU KYOGIKAI
Priority to JP56029427A priority Critical patent/JPS57144294A/en
Publication of JPS57144294A publication Critical patent/JPS57144294A/en
Publication of JPS6210517B2 publication Critical patent/JPS6210517B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は抗乳酸菌活性と抗腫瘍活性をもつ新抗
生物質248−Sq−2A物質および248−Sq−2B物
質、ならびにその製造法に関する。以下、単に
248−Sq−2物質と記載するときは248−Sq−2A
物質または248−Sq−2B物質あるいはこれらの混
合物を指す。 本発明者は長野県で採取した土壤試料から分離
されたストレプトミセス属の菌株で248−Sq 2
の番号を与えた微生物の培養液中に抗乳酸菌活性
をもつ2つの物質が存在することを見出し、これ
ら物質を単離、精製し、さらに新規物質であるこ
とを認めて248−Sq−2A物質、248−Sq−2B物質
と命名してその物理化学的および生物学的性質を
研究した。 本発明の248−Sq−2Aおよび248−Sq−2B物質
は共通してそれぞれ次の諸性質を有する。これら
は白色非結晶性の粉末であり、水に易溶、アルコ
ール類たとえばメタノールに僅溶、ケトン類例え
ばアセトン、および酢酸エチル、塩素化炭化水素
溶媒、例えばクロロホルムに事実上不溶、その融
点は220℃(分解を伴なう)である。 248−Sq−2A物質の紫外吸収スペクトル(水中
25mg/3c.c.の濃度で測定)は220nmまで特徴的
吸収を示さず、その赤外吸収スペクトル(臭化カ
リウム錠で測定)を添付図面の第1図に示した。
主な赤外吸収帯〔波数(cm-1)〕は次の通りであ
る。 3260(s) 2880(w) 1660(s) 1530(m) 1410(m) 1230(m) 1165(w) 1155(w) 1050(m) 960(w) 但し、s=強、m=中程度、w=弱を示す。 248−Sq−2A物質は下記の混合溶媒系で展開す
るとシリカゲル薄層の上昇クロマトグラフイーで
次の如く単一スポツトを与える。 (1) クロロホルム−メタノール−アンモニア水
(2:3:1容量比)の展開溶媒でRf0.75 (2) ブタノール−酢酸−水(4:1:2)の展開
溶媒でRf0.25 248−Sq−2A物質は、炭素、水素、窒素および
酸素を含む。その元素組成は、おおよそ次の通り
である。 C51.10%、H7.14%、N15.83%、O26.37%その
元素分析、プロトンNMRスペクトル(添付図面
の第3図)、ならびに炭素13C NMRのスペクトル
から248−Sq−2A物質は次の実験式C31H52N8O12
を有すると思われる。更にプロトンNMRスペク
トルおよび炭素13C NMRスペクトルは248−Sq−
2Aの分子内に六つのメチル基が存在することを
示す。 248−Sq−2A物質の紫外吸収スペクトル(水中
25mg/3c.c.の濃度で測定)は220nmまで特徴的
吸収を示さず、その赤外吸収スペクトル(臭化カ
リウム錠で測定)を添付図面の第2図に示す。主
な赤外吸収帯〔波数(cm-1)〕は次の通りである。 3260(s) 2880(w) 1660(s) 1530(m) 1410(m) 1230(m) 1165(w) 1155(w) 1050(m) 960(w) 但し、s=強、m=中程度、w=弱を示す。 248−Sq−2B物質は下記の混合溶媒系を用いる
シリカゲル薄層の上昇クロマトグラフイーで次の
如く単一スポツトを与える。 (1) クロロホルム−メタノール−アンモニア水
(2:3:1容量比)の展開溶媒でRf0.70 (2) ブタノール−酢酸−水(4:1:2)の展開
溶媒でRf0.20 248−Sq−2B物質は炭素、水素、窒素および酸
素を含む。その元素組成はおおよそ次の通りであ
る。 C48.98%、H6.71%、N16.33%、O27.99%その
元素分析、プロトンNMRスペクトル(添付図面
の第4図)、ならびに炭素13C NMRのスペクトル
から248−Sq−2Bは次の実験式C28H46N8O12を有
すると思われる。更にプロトンNMRスペクトル
および炭素13C NMRスペクトルは248−Sq−2B
の分子内に五つのメチル基が存在することを示
す。 本発明の248−Sq−2物質は次に述べる抗菌性
を有する。 248−Sq−2Aおよび248−Sq−2A物質はある種
のグラム陽性菌に対して静菌活性を示す。幾つか
の微生物に対する248−Sq−2Aおよび248−Sq−
2Bの静菌活性を常用の倍数希釈法で測定された
最小生育阻止濃度(M.I.C.)(mcg/ml)で次表
に示す。
The present invention relates to new antibiotic substances 248-Sq-2A and 248-Sq-2B having anti-lactic acid bacterium activity and anti-tumor activity, and a method for producing the same. Below, simply
248-Sq-2A when describing 248-Sq-2 substance
substance or 248-Sq-2B substance or a mixture thereof. The present inventor discovered a 248-Sq 2 strain of Streptomyces isolated from a soil sample collected in Nagano Prefecture.
It was discovered that two substances with anti-lactic acid bacterium activity existed in the culture solution of the microorganism given the number 248-Sq-2A substance. , named the substance 248-Sq-2B, and studied its physicochemical and biological properties. The 248-Sq-2A and 248-Sq-2B materials of the present invention each have the following properties in common. They are white amorphous powders, readily soluble in water, sparingly soluble in alcohols such as methanol, virtually insoluble in ketones such as acetone, and ethyl acetate, chlorinated hydrocarbon solvents such as chloroform, their melting point is 220 °C (with decomposition). Ultraviolet absorption spectrum of 248-Sq-2A substance (in water)
(measured at a concentration of 25 mg/3 c.c.) showed no characteristic absorption up to 220 nm, and its infrared absorption spectrum (measured with a potassium bromide tablet) is shown in Figure 1 of the accompanying drawings.
The main infrared absorption bands [wave numbers (cm -1 )] are as follows. 3260 (s) 2880 (w) 1660 (s) 1530 (m) 1410 (m) 1230 (m) 1165 (w) 1155 (w) 1050 (m) 960 (w) However, s = strong, m = medium , w=weak. When the 248-Sq-2A substance is developed with the mixed solvent system shown below, it gives a single spot in ascending chromatography on a thin layer of silica gel as shown below. (1) Rf0.75 with a developing solvent of chloroform-methanol-ammonia water (2:3:1 volume ratio) (2) Rf0.25 with a developing solvent of butanol-acetic acid-water (4:1:2) 248-Sq -2A substances include carbon, hydrogen, nitrogen and oxygen. Its elemental composition is approximately as follows. C51.10%, H7.14%, N15.83%, O26.37% From its elemental analysis, proton NMR spectrum (Figure 3 of the attached drawing), and carbon 13 C NMR spectrum, the 248-Sq-2A substance is The following empirical formula C 31 H 52 N 8 O 12
It seems to have the following. Furthermore, the proton NMR spectrum and carbon 13 C NMR spectrum are 248−Sq−
Shows the presence of six methyl groups in the molecule of 2A. Ultraviolet absorption spectrum of 248-Sq-2A substance (in water)
(measured at a concentration of 25 mg/3 c.c.) shows no characteristic absorption up to 220 nm, and its infrared absorption spectrum (measured with potassium bromide tablets) is shown in Figure 2 of the accompanying drawings. The main infrared absorption bands [wave numbers (cm -1 )] are as follows. 3260 (s) 2880 (w) 1660 (s) 1530 (m) 1410 (m) 1230 (m) 1165 (w) 1155 (w) 1050 (m) 960 (w) However, s = strong, m = medium , w=weak. The 248-Sq-2B material yields a single spot on silica gel thin layer ascending chromatography using the mixed solvent system described below. (1) Rf0.70 with a developing solvent of chloroform-methanol-ammonia water (2:3:1 volume ratio) (2) Rf0.20 with a developing solvent of butanol-acetic acid-water (4:1:2) 248-Sq -2B substances include carbon, hydrogen, nitrogen and oxygen. Its elemental composition is approximately as follows. C48.98%, H6.71%, N16.33%, O27.99% From its elemental analysis, proton NMR spectrum (Figure 4 of the attached drawing), and carbon 13 C NMR spectrum, 248-Sq-2B is as follows. It appears to have the empirical formula of C 28 H 46 N 8 O 12 . Furthermore, the proton NMR spectrum and carbon 13C NMR spectrum are 248−Sq−2B
shows that there are five methyl groups in the molecule of The 248-Sq-2 substance of the present invention has the following antibacterial properties. 248-Sq-2A and 248-Sq-2A substances exhibit bacteriostatic activity against certain Gram-positive bacteria. 248−Sq−2A and 248−Sq− against some microorganisms
The bacteriostatic activity of 2B is shown in the following table as the minimum inhibitory concentration (MIC) (mcg/ml) determined by the conventional multiple dilution method.

【表】【table】

【表】 更に、248−Sq−2A、および248−Sq−2B物質
は次表に示す組成の合成培地上で乳酸菌を生育さ
せた際に強い抗乳酸菌活性を示す。
[Table] Furthermore, substances 248-Sq-2A and 248-Sq-2B exhibit strong anti-lactic acid bacteria activity when lactic acid bacteria are grown on a synthetic medium with the composition shown in the following table.

【表】 本合成培地上での乳酸菌(Lactobacillus
casei)に対する最小生育阻止濃度は248−Sq−
2A物質で0.3mcg/ml、また248−Sq−2B物質で
0.5mcg/mlである。 更に、本発明の248−Sq−2物質についてその
抗腫瘍活性を見るために、サルの腫瘍ウイルス
SV−40の感染により腫瘍転換した細胞と正常細
胞とに供給物質を作用させた後にその細胞の形態
の変化の差を観察して抗腫瘍活性を評価する標準
方法に従つて試験すると、248−Sq−2Aおよび
248−Sq−2B物質は50mcg/mlの濃度で抗腫瘍活
性があることが認められ、本発明の新規物質は抗
腫瘍剤としての用途が期待される。 本発明の第2の要旨は、ストレプトミセス属に
属する248−Sq−2物質生産菌を培養し、その培
養物から248−Sq−2A物質又は248−Sq−2B物質
又はこれらの混合物を採取することを特徴とする
抗生物質248−Sq−2物質の製造法にある。248
−Sq−2物質生産菌の一例としては、本発明者
により長野県で採取した土壤試料から分離された
前述のストレプトミセス属の248−Sq−2株があ
る。この菌株は工業技術院微生物工業技術研究所
に昭和56年2月18日、寄託番号5882号で寄託され
てある。 この菌株は、少量の土壤試料を滅菌蒸留水中に
けん濁し、このけん濁液を種々な濃液に希釈し、
そして各希釈液の少量を栄養寒天培地を含むペト
リ皿の表面に拡げ、微生物の発育を許す27℃で2
〜3日間インキユベーシヨン後、コロニーを取り
出し、斜面栄養寒天に移植して一層豊富な培養を
作り出すようにして一般の菌単離法に従つて単離
されたものである。 この248−Sq−2株の菌学的性質を次に記載す
るが、この菌株はストレプトミセス・シイラタス
の一新菌株であると認められた。 (a) 形態的性状 栄養菌糸は巾0.5〜0.9μm、単軸分枝、寒天
培地上では分断しないが、液体培地で振盪培養
するとコリネバクテリア状に分断する。空中菌
糸は比較的短い主軸上に短い胞子柄を房状に単
軸分枝し、その上に長い胞子鎖を着生する。胞
子鎖は通常直状、まれに曲状、ループ状を示
し、10〜50個またはそれ以上の胞子からなつて
いる。胞子は長円形(0.6〜0.8×1.3〜2.0μ
m)または指骨形(フアランギフオーム;0.3
〜0.5×1.3〜2.0μm)、平滑表面を呈す。特殊
形態として集中菌糸、空中菌核状物体を形成
し、胞子のう、運動性胞子などは観察されな
い。 (b) 細胞壁タイプ 全細胞加水分解法によりヂアミノピメリン酸
(DAP)の糖成分を調べた。LL−DAPを含み
メゾ−DAPを含まず、分類指標となる糖を含
まない。すなわち、細胞壁タイプを示す。 (c) 培養性状 培養性状はISPの方法に準じて観察し、下記
の第3表に示す。 (d) 生理的性状 生理的性状は後記の第4表に示す。
[Table] Lactic acid bacteria (Lactobacillus) on this synthetic medium
The minimum inhibitory concentration for (casei) is 248−Sq−
0.3mcg/ml for 2A substance and 248−Sq−2B substance
It is 0.5mcg/ml. Furthermore, in order to examine the antitumor activity of the 248-Sq-2 substance of the present invention, monkey tumor virus
When tested according to the standard method of evaluating anti-tumor activity by observing the difference in the changes in the morphology of the cells after applying the supplied substance to cells that had undergone tumor transformation due to SV-40 infection and normal cells, 248- Sq−2A and
Substance 248-Sq-2B was found to have antitumor activity at a concentration of 50mcg/ml, and the novel substance of the present invention is expected to be used as an antitumor agent. The second gist of the present invention is to culture a 248-Sq-2 substance-producing bacterium belonging to the genus Streptomyces, and collect a 248-Sq-2A substance, a 248-Sq-2B substance, or a mixture thereof from the culture. A method for producing an antibiotic 248-Sq-2 substance is provided. 248
An example of a -Sq-2 substance-producing bacterium is the aforementioned 248-Sq-2 strain of the genus Streptomyces, which was isolated by the present inventor from a soil sample collected in Nagano Prefecture. This strain was deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology on February 18, 1982, with deposit number 5882. This strain was obtained by suspending a small amount of soil sample in sterile distilled water and diluting this suspension to various concentrations.
A small amount of each dilution was then spread on the surface of a Petri dish containing nutrient agar and incubated at 27°C for 2 hours to allow microbial growth.
After ~3 days of incubation, colonies were picked and transplanted onto slanted nutrient agar to create a more abundant culture and isolated according to conventional bacterial isolation methods. The mycological properties of this 248-Sq-2 strain are described below, and this strain was recognized to be a new strain of Streptomyces syiratus. (a) Morphological characteristics The vegetative hyphae are 0.5 to 0.9 μm wide, uniaxially branched, and do not divide on agar medium, but when cultured with shaking in liquid medium, they divide into corynebacteria. Aerial hyphae have short sporophytes branching uniaxially in clusters on a relatively short main axis, and long spore chains are attached to them. Spore chains are usually straight, rarely curved or looped, and consist of 10 to 50 or more spores. Spores are oblong (0.6-0.8 x 1.3-2.0μ
m) or phalange form (phalangiform; 0.3
~0.5×1.3~2.0 μm), exhibiting a smooth surface. As a special form, concentrated hyphae and aerial sclerotium-like objects are formed, and sporangia and motile spores are not observed. (b) Cell wall type The sugar components of diaminopimelic acid (DAP) were investigated using whole cell hydrolysis method. Contains LL-DAP, does not contain meso-DAP, and does not contain sugars that serve as classification indicators. That is, it indicates the cell wall type. (c) Culture properties Culture properties were observed according to the ISP method and are shown in Table 3 below. (d) Physiological properties Physiological properties are shown in Table 4 below.

【表】【table】

【表】【table】

【表】 (e) 炭素源の同化性 プリドハム・ゴドリーブ寒天培地を用いて観
察し、結果は第5表に示す。
[Table] (e) Assimilation of carbon source Observation was made using Pridham-Godelive agar medium, and the results are shown in Table 5.

【表】【table】

【表】 放線菌248−Sq2株はその形態学的性状と細胞
壁タイプIであることよりストレプトミセス属に
包含されると判断される。 本菌株は菌叢色が赤色系列と灰色系列との両者
にまたがり、胞子鎖の形態も直状(RF)ときに
曲状からループ状(RA)を示し、空中菌核状物
体を形成し、平滑胞子を着生する。これらの特性
と炭素源の同化性を基準にして、バージー氏細菌
同定便覧及びISP記載により検索した。その結
果、ストレプトミセス・シラタス(S.
cirratus)、ストレプトミセス・ポリクロモゲネ
ス(S.polychromogenes)の2種が本菌株に近縁
であり、菌叢色が赤色と灰色の両系列にまたがる
前者が最も近縁であると判断される。 本菌株は胞子鎖が通常RFを示し、典形的RAで
ない点、メラニン様色素を形成しない点でストレ
プトミセス・シラタスの標準株と異なる。一般に
RFとRAの両形態を示す菌株は培地組成、PH、温
度など培養条件により両形態の発現度合が変える
ことが知られており、ストレプトミセス・シラタ
ス標準株のメラニン様色素生成の陽性度はあまり
明確でないことなどの理由により、これらの相異
点は明確に種を分ける基準とは判断されない。よ
つて、本菌株はストレプトミセス・シラタスの新
菌株と同定し、ストレプトミセス・シラタス
(Streptomyces cirratus KOSHIYAMA et.al.)
248−Sq2株と称する。 本発明の方法では248−Sq−2物質生産菌、例
えば248−Sq−2株(FERM−P5882)を通常の
微生物が利用しうる栄養物を含有する培地で培養
する。栄養源としては、従来ストレプトミセス属
の菌の培養に利用されている公知のものが使用で
きる。例えば炭素源としてグルコース、澱粉、グ
リセリン、シユクロース、水あめ、糖密等を使用
しうる。また窒素源として大豆粉、小麦胚芽、肉
エキス、ペプトン、乾燥酵母、コーンステイープ
リカー、硫酸アンモン、硝酸ソーダ等を使用しう
る。その他必要に応じて炭酸カルシウム、食塩、
塩化カリ、燐酸塩等の無機塩類を添加するほか、
菌の発育を助け、248−Sq−2物質の生産を促進
するごとき有機及び無機物を適当に添加すること
が出来る。 培養法としては、一般抗生物質生産の方法と同
じく、液体培養法、特に深部培養法が最も適して
いる。培養は好気的条件下で行われ、培養に適当
な温度は25〜35℃であるが、多くの場合、27℃付
近で培養する。かくして248−Sq−2物質の生産
は振盪培養、タンク培養共に3〜5日で最高に達
する。 248−Sq−2物質は主として培養物の液体部分
に存在するが後記の理化学性状で示すように水溶
性の物質であるのでその抽出・精製にあたつては
活性炭、ダイヤイオンHPのような微多孔の非イ
オン性吸着樹脂あるいはアンバーライトIR−
120、ダウエツクス50W等の陽イオン交換樹脂を
使用して吸着させ、これを有機溶媒又は適当な酸
溶液を用いて溶出することが出来る。 例えば培養液をダウエツクス50W(H型)の
樹脂塔を通過させ、有効成分を樹脂部に吸着さ
せ、これを0.5M−ピリジン−酢酸溶液で溶出す
る方法は本物質の精製法として有効な手段であ
る。 このような方法で得られた248−Sq−2物質の
粗粉末はセルロース、シリカゲル、アルミナ乃至
はセフアデツクスを使用するクロマトグラフイー
によつてさらに純度を高めることが出来る。 かくして得られた248−Sq−2物質は白色の無
定形粉末である。 248−Sq−2A物質と−2B物質との分離はシリ
カゲル又はセフアデツクスG−25のカラムに吸着
させた後にブタノール−酢酸−水(4:1:2容
比)で展開することにより行われる。 次に実施例により本発明の方法を説明する。 実施例 1 (イ) ストレプトミセス・シラタス248−Sq2株
(FERM−P5882)のスラントから1白金耳を
とり、滅菌されたYH培地を入れた15mlの試験
管内に接種、27℃で48時間振とう培養して前々
培養物を得た。デキストリン25g、大豆粉20
g、NaCl 5g、CaCO34gを水で1にした
滅菌された培地(PH6.4)100mlを500mlの三角
フラスコに入れ、上記の前々培養物の2mlを接
種し27℃で72時間振とう培養して前培養液を得
た。 (ハ) 次の成分よりなる生産培地を30の醗酵器に
導入する。 デキストリン 375g 大豆粉 300g NaCl 75g CaCO3 60g 水道水 (13とするに十分な量) PHを4N塩酸溶液の添加により0.4に調節す
る。この培地をその中に122℃の水蒸気を20分
間通入することにより滅菌する。冷却後、培養
液の容種は滅菌過程で水蒸気が凝縮するために
15になりPHは7.0である。次にこれに上記の
前培養液(300ml)を接種する。培養を27℃で
72時間行つた。この間、400回転/分で回転す
るタービンにより撹拌し滅菌し空気(30/
分)を通気する。この操作の終りで培養液のPH
7.8であり容積は14であつた。 (ハ) 上記のようにして得た培養液14に過助剤
(500g)を加えて過し、培養液を得る。
液をダイヤイオンHP−20のカラム(3)に
通し吸着後、メタノール(10)により溶出を
行なう。上記のようにして得た溶出液を減圧濃
縮によりメタノールを除き、濃縮液をダウエツ
クス50のカラムに通す。カラムを水洗後、5%
ピリジン水溶液(10)にて吸着物質を溶出す
る。減圧濃縮後PHを7.0に調節し、次にダイヤ
イオンHP−20のカラムに通し、水→100%メタ
ノールのグラジエント溶出を行なう。ここで2
通りの活性な区分A及びBが得られる。それぞ
れの活性区分を集め、減圧濃縮し、続いてダウ
エツクス50レジンでクロマトグラフイーをそれ
ぞれ行なう。0.5Mピリジン−酢酸溶液にて溶
出し、活性区分をそれぞれ集め減圧濃縮を行な
う。次にセフアデツクスG−25で分配クロマト
グラフイーをそれぞれ行なう。溶出をブタノー
ル−酢酸−水(4:1:2)で行ない、活性区
分をそれぞれ集め減圧濃縮を行なう。続いてセ
フアデツクスG−50のカラムに通し、活性区分
をそれぞれ濃縮、凍結乾燥により、248−Sq−
2A物質の50mg、248−Sq−2B物質の30mgを得
る。 実施例 2 実施例1(ロ)と同様にして得た培養液14に過
助剤(500g)を加え培地を過し培養液を得
る。液(13)に活性炭500gを加え20分間撹
拌、過を行なう。次に活性炭を70%アセトン水
(10)(PH2.0)に混入し撹拌、過を行ない
液を得る。これに塩酸水溶液を加えPH7.0とし、
減圧濃縮を行ない、アセトンを除去して粗抽出液
(3)を得る。 上記のようにして得た粗抽出液をダウエツクス
50のカラムに通す。カラムを水洗後、5%ピリジ
ン水溶液(10)にて吸着物質を溶出する。減圧
濃出後PHを7.0に調節し、次にダイヤイオンHP20
のカラムに通し、水→100%メタノールのグラジ
エンド溶出を行なう。ここで2通りの活性区分
A、Bが得られる。それぞれの活性区分を集め減
圧濃縮し続いてダウエツクス50レジンでクロマト
グラフイーをそれぞれ行なう。0.5Mピリジン−
酢酸溶液にて溶出し、活性区分をそれぞれ集め減
圧濃縮を行なう。次にセフアデツクスG−25で分
配クロマトグラフイーをそれぞれ行なう。溶出は
ブタノール−酢酸−水(4:1:2)混液を用
い、活性区分をそれぞれ集め、減圧濃縮を行な
う。続いてセフアデツクスG−50のカラムに通
し、活性区分をそれぞれ濃縮凍結乾燥により248
−Sq−2A物質の50mg、248−Sq−2B物質の30mg
を得た。
[Table] Actinomycetes strain 248-Sq2 is judged to be included in the genus Streptomyces based on its morphological characteristics and cell wall type I. This strain has a flora color that spans both the red and gray series, and the morphology of the spore chain varies from straight (RF) to curved to looped (RA), forming aerial sclerotium-like objects. Smooth spores are attached. Based on these characteristics and assimilability of carbon sources, a search was conducted using Mr. Burgee's bacterial identification handbook and ISP descriptions. As a result, Streptomyces siratus (S.
S. cirratus) and Streptomyces polychromogenes (S. polychromogenes) are closely related to this strain, and the former, whose bacterial flora colors span both red and gray series, is judged to be the most closely related. This strain differs from the standard strain of Streptomyces siratus in that its spore chains usually exhibit RF, it is not a typical RA, and it does not form melanin-like pigments. in general
It is known that in strains that exhibit both RF and RA forms, the degree of expression of both forms changes depending on culture conditions such as medium composition, pH, and temperature, and the degree of positivity for melanin-like pigment production in the standard strain of Streptomyces siratus is not very high. For reasons such as lack of clarity, these differences cannot be judged as criteria for clearly separating species. Therefore, this bacterial strain was identified as a new strain of Streptomyces cirratus, and is related to Streptomyces cirratus KOSHIYAMA et.al.
It is called 248−Sq2 strain. In the method of the present invention, a 248-Sq-2 substance-producing bacterium, such as the 248-Sq-2 strain (FERM-P5882), is cultured in a medium containing nutrients that can be used by ordinary microorganisms. As the nutrient source, any known nutrient source that has been conventionally used for culturing Streptomyces bacteria can be used. For example, glucose, starch, glycerin, sucrose, starch syrup, molasses, etc. can be used as the carbon source. Also, soybean flour, wheat germ, meat extract, peptone, dry yeast, cornstarch liquor, ammonium sulfate, sodium nitrate, etc. can be used as the nitrogen source. Calcium carbonate, salt, etc. as necessary.
In addition to adding inorganic salts such as potassium chloride and phosphates,
Organic and inorganic substances that aid the growth of bacteria and promote the production of 248-Sq-2 substances can be added as appropriate. As for the culture method, the liquid culture method, especially the deep culture method, is most suitable, as is the case with general antibiotic production methods. Cultivation is carried out under aerobic conditions, and the appropriate temperature for cultivation is 25 to 35°C, but in most cases it is cultured at around 27°C. Thus, the production of 248-Sq-2 substance reaches its maximum in 3 to 5 days in both shaking culture and tank culture. The 248-Sq-2 substance mainly exists in the liquid part of the culture, but as shown in the physical and chemical properties below, it is a water-soluble substance, so when extracting and purifying it, a microorganism such as activated carbon or Diaion HP is used. Porous non-ionic adsorption resin or Amberlite IR-
120, Dowex 50W or the like can be used for adsorption, and this can be eluted using an organic solvent or a suitable acid solution. For example, passing the culture solution through a Dowex 50W (H type) resin column, adsorbing the active ingredient to the resin, and eluting it with a 0.5M pyridine-acetic acid solution is an effective method for purifying this substance. be. The crude powder of 248-Sq-2 material obtained in this manner can be further purified by chromatography using cellulose, silica gel, alumina or Sephadex. The 248-Sq-2 material thus obtained is a white amorphous powder. The 248-Sq-2A substance and the -2B substance are separated by adsorption onto a column of silica gel or Sephadex G-25, followed by development with butanol-acetic acid-water (4:1:2 volume ratio). The method of the invention will now be explained by way of examples. Example 1 (a) One platinum loop was taken from a slant of Streptomyces siratus strain 248-Sq2 (FERM-P5882), inoculated into a 15 ml test tube containing sterilized YH medium, and shaken at 27°C for 48 hours. A pre-previous culture was obtained by culturing. 25g dextrin, 20g soybean flour
Put 100 ml of a sterilized medium (PH 6.4) containing 5 g of NaCl, 4 g of CaCO 3 to 1 volume with water into a 500 ml Erlenmeyer flask, inoculate with 2 ml of the above pre-prepared culture, and shake at 27°C for 72 hours. A preculture solution was obtained by culturing. (c) Introduce a production medium consisting of the following ingredients into 30 fermenters. Dextrin 375g Soy flour 300g NaCl 75g CaCO 3 60g Tap water (enough to make 13) Adjust PH to 0.4 by adding 4N hydrochloric acid solution. The medium is sterilized by passing water vapor at 122°C through it for 20 minutes. After cooling, the volume of the culture medium will change due to condensation of water vapor during the sterilization process.
15 and the pH is 7.0. Next, inoculate this with the above preculture solution (300 ml). Culture at 27℃
I went for 72 hours. During this time, the air is stirred and sterilized by a turbine rotating at 400 rpm (30 rpm).
minutes). At the end of this operation the pH of the culture medium is
7.8 and the volume was 14. (c) Add a supernatant (500 g) to the culture solution 14 obtained as described above and filter it to obtain a culture solution.
The solution is passed through a Diaion HP-20 column (3) for adsorption, and then eluted with methanol (10). The eluate obtained as described above is concentrated under reduced pressure to remove methanol, and the concentrated solution is passed through a Dowex 50 column. After washing the column with water, 5%
Elute the adsorbed substance with an aqueous pyridine solution (10). After concentration under reduced pressure, adjust the pH to 7.0, then pass through a Diaion HP-20 column and perform gradient elution from water to 100% methanol. Here 2
Two active sections A and B are obtained. Each active fraction was collected, concentrated under reduced pressure, and then individually chromatographed on Dowex 50 resin. Elute with 0.5M pyridine-acetic acid solution, collect active fractions, and concentrate under reduced pressure. Next, partition chromatography was performed using Sephadex G-25. Elution was performed with butanol-acetic acid-water (4:1:2), and the active fractions were collected and concentrated under reduced pressure. Next, the active fractions were passed through a Sephadex G-50 column, concentrated, and freeze-dried to 248-Sq-
Obtain 50 mg of 2A substance and 30 mg of 248-Sq-2B substance. Example 2 A supporting agent (500 g) is added to the culture solution 14 obtained in the same manner as in Example 1 (b), and the medium is filtered to obtain a culture solution. Add 500 g of activated carbon to liquid (13), stir for 20 minutes, and filter. Next, mix activated carbon into 70% acetone water (10) (PH2.0), stir and filter to obtain a liquid. Add hydrochloric acid aqueous solution to this to make the pH 7.0,
Concentrate under reduced pressure to remove acetone to obtain a crude extract (3). Dowex the crude extract obtained as above.
Pass through 50 columns. After washing the column with water, the adsorbed substance is eluted with a 5% aqueous pyridine solution (10). After concentration under reduced pressure, adjust the pH to 7.0, then use Diaion HP20.
column and perform gradient elution of water → 100% methanol. Here, two types of activity categories A and B are obtained. Each active fraction was collected and concentrated under reduced pressure, followed by chromatography using Dowex 50 resin. 0.5M pyridine
Elute with acetic acid solution, collect active fractions, and concentrate under reduced pressure. Next, partition chromatography was performed using Sephadex G-25. For elution, a mixture of butanol-acetic acid-water (4:1:2) is used, and the active fractions are collected and concentrated under reduced pressure. Subsequently, it was passed through a column of Sephadex G-50, and each active fraction was concentrated and lyophilized to 248
-50 mg of Sq-2A substance, 30 mg of 248-Sq-2B substance
I got it.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図及び第2図は夫々に本発明の248−Sq−
A及び−B物質の赤外吸収スペクトル図であり、
第3図及び第4図はプロトンNMRスペクトル図
である。
Figures 1 and 2 respectively show 248-Sq- of the present invention.
It is an infrared absorption spectrum diagram of substances A and -B,
3 and 4 are proton NMR spectra.

Claims (1)

【特許請求の範囲】 1 白色非結晶性の粉末で水に易溶、アルコール
類たとえばメタノールに僅溶、ケトン類たとえば
アセトンおよび酢酸エチル、塩素化炭化水素溶媒
たとえばクロロホルムに事実上不溶、融点は220
℃(分解を伴なう)であり、紫外吸収スペクトル
に特徴的吸収を示さず、赤外吸収スペクトル(臭
化カリウム錠で測定)で波数3260、2880、1660、
1530、1410、1230、1165、1155、1050および960
cm-1に吸収帯を示し、クロロホルム−メタノール
−アンモニア水(2:3:1容量比)を用いたシ
リカゲルの薄層上昇クロマトグラフイーで0.75の
Rfを有しブタノール−酢酸−水(4:1:2容
量比)を用いたシリカゲルの薄層上昇クロマトグ
ラフイーで0.25のRfを有し、その元素組成はおお
よそC51.10%、H7.14%、N15.38%、O26.37%で
ある抗乳酸菌活性を有する248−Sq−2A物質と、
白色非結晶性の粉末で水に易溶、アルコール類た
とえばメタノールに僅溶、ケトン類たとえばアセ
トンおよび酢酸エチル、塩素化炭化水素溶媒たと
えばクロロホルムに事実上不溶、融点は220℃
(分解を伴なう)であり、紫外吸収スペクトルに
特徴的吸収を示さず、赤外吸収スペクトル(臭化
カリウム錠で測定)では波数3260、2880、1660、
1530、1410、1230、1165、1155、1050および960
cm-1に吸収帯を示し、クロロホルム−メタノール
−アンモニア水(2:3:1容量比)を用いたシ
リカゲルの薄層上昇クロマトグラフイーで0.70の
Rfを有し、ブタノール−酢酸−水(4:1:2
容量比)を用いたシリカゲルの薄層上昇クロマト
グラフイーで0.20のRfを有し、その元素組成は
C48.98%、H6.71%、N16.33%、O27.99%である
抗乳酸菌活性を有する248−Sq−2B物質とからな
る群から選ばれる抗生物質248−Sq−2物質。 2 ストレプトミセス属に属する248−Sq−2物
質生産菌を培養し、その培養物から248−Sq−2A
物質又は248−Sq−2B物質又はこれらの混合物を
採取することを特徴とする抗生物質248−Sq−2
物質製造法。
[Claims] 1. White amorphous powder, easily soluble in water, slightly soluble in alcohols such as methanol, virtually insoluble in ketones such as acetone and ethyl acetate, chlorinated hydrocarbon solvents such as chloroform, melting point 220
°C (accompanied by decomposition), does not show any characteristic absorption in the ultraviolet absorption spectrum, and has wave numbers of 3260, 2880, 1660, and
1530, 1410, 1230, 1165, 1155, 1050 and 960
It shows an absorption band at 0.75 cm -1 and was determined by thin layer ascending chromatography on silica gel using chloroform-methanol-aqueous ammonia (2:3:1 volume ratio).
Thin layer elevation chromatography on silica gel using butanol-acetic acid-water (4:1:2 volume ratio) has an Rf of 0.25, and its elemental composition is approximately C51.10%, H7.14 %, N15.38%, O26.37%, 248-Sq-2A substance with anti-lactic acid bacterium activity;
White amorphous powder, readily soluble in water, sparingly soluble in alcohols such as methanol, virtually insoluble in ketones such as acetone and ethyl acetate, chlorinated hydrocarbon solvents such as chloroform, melting point 220°C
(accompanied by decomposition), and does not show any characteristic absorption in the ultraviolet absorption spectrum, and the infrared absorption spectrum (measured with potassium bromide tablets) shows wave numbers of 3260, 2880, 1660,
1530, 1410, 1230, 1165, 1155, 1050 and 960
It shows an absorption band at 0.70 cm -1 and a
Rf, butanol-acetic acid-water (4:1:2
It has an Rf of 0.20 in thin layer ascending chromatography of silica gel using (volume ratio), and its elemental composition is
An antibiotic 248-Sq-2 substance selected from the group consisting of 248-Sq-2B substance having anti-lactic acid bacterium activity of C48.98%, H6.71%, N16.33%, O27.99%. 2. Cultivate 248-Sq-2 substance-producing bacteria belonging to the genus Streptomyces, and use the culture to produce 248-Sq-2A.
Antibiotics 248-Sq-2 characterized by collecting the substance or 248-Sq-2B substance or a mixture thereof
Substance manufacturing method.
JP56029427A 1981-03-03 1981-03-03 New antibiotic substance 248-sq-2 and its preparation Granted JPS57144294A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56029427A JPS57144294A (en) 1981-03-03 1981-03-03 New antibiotic substance 248-sq-2 and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56029427A JPS57144294A (en) 1981-03-03 1981-03-03 New antibiotic substance 248-sq-2 and its preparation

Publications (2)

Publication Number Publication Date
JPS57144294A JPS57144294A (en) 1982-09-06
JPS6210517B2 true JPS6210517B2 (en) 1987-03-06

Family

ID=12275831

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56029427A Granted JPS57144294A (en) 1981-03-03 1981-03-03 New antibiotic substance 248-sq-2 and its preparation

Country Status (1)

Country Link
JP (1) JPS57144294A (en)

Also Published As

Publication number Publication date
JPS57144294A (en) 1982-09-06

Similar Documents

Publication Publication Date Title
JPS61247396A (en) Production of genisteine
JPS6210517B2 (en)
JP3048513B2 (en) 2,2'-bipyridine derivative, method for producing the same, and antitumor agent containing the derivative
US5516686A (en) Fungicidal antibiotic producing Streptomyces sp. NCIMB 40212
JPH0353891A (en) New antibiotic substance sf2197c and production thereof
JP2592468B2 (en) Benanomycins A and B, novel antibiotics and their production
JPH0120153B2 (en)
JP3796540B2 (en) Method for producing yellow pigment
JP3327982B2 (en) New antibiotic MI481-42F4-A related substance
JPH02306992A (en) Antibiotic pk-1061g and pk-1061h and production thereof
JPS61289898A (en) Production of factor for suppressing sporulation of phytopathogenic fungus
JP2594085B2 (en) SF2575, a new antitumor antibiotic, and method for producing the same
JPS6219599A (en) Novel macrolide antibiotic m119
KR830000618B1 (en) Preparation method of new antibiotic SF-2050B
JPS6322799B2 (en)
JPS5934896A (en) Preparation of antitumor polysaccharide
JPS62210996A (en) Production of antibiotic substance emimycin
JPS61289005A (en) Plant pathogenic germ sporulation inhibitor
JPS5932120B2 (en) Method for producing 9-β-D arabinofuranosyl adenine
JPS63255292A (en) Antibiotic rk-16 and production thereof
JPS5915634B2 (en) Production method of actinomycin by fermentation method
JPS5918035B2 (en) Antibiotic AB-85
JPS62132897A (en) Physiologically active substance k-13 and production thereof
JPS60234593A (en) Production of pseudodisaccharide compound by microorganism
JPH03220196A (en) Benzanthraquinone compound